Author

Boris Weimann

Observed name: Weimann, Boris

OpenAlex ID: A5015913879

Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study

2013 · Heino Stass, Boris Weimann, et al. · Clinical Therapeutics · 63

Pharmacokinetics of a New Orodispersible Tablet Formulation of Vardenafil

2010 · Roland Heinig, Boris Weimann, et al. · Clinical Drug Investigation · 44

Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers

2016 · Heino Stass, Johannes Nagelschmitz, et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 25

Biopharmaceutical Characteristics of Nifurtimox Tablets for Age‐ and Body Weight‐Adjusted Dosing in Patients With Chagas Disease

2020 · Heino Stass, Ethel Feleder, et al. · Clinical Pharmacology in Drug Development · 20

Clinical investigation of the biopharmaceutical characteristics of nifurtimox tablets – Implications for quality control and application

2021 · Heino Stass, Sarah Just, et al. · European Journal of Pharmaceutical Sciences · 17

Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis

2019 · Heino Stass, Johannes Nagelschmitz, et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 5

Safety, Tolerability And Pharmacokinetics Of Ciprofloxacin Dry Powder For Inhalation In Patients With Mild To Moderate Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial

2011 · Heino Stass, Johannes Nagelschmitz, et al. · American Journal of Respiratory and Critical Care Medicine · 4

Abstract 19938: VEriciguat NItroglycerin Clinical IntEraction (VENICE): A Phase 1, Multicenter, Randomized, Placebo-controlled, Double-blind Group-comparison Study in Patients With Stable Coronary Artery Disease to Evaluate Tolerability and Blood Pressure Effects of Nitroglycerin After Pre-treatment With Multiple Oral Doses of Vericiguat

2017 · Hans-Dirk Düengen, Frank Donath, et al. · Circulation · 3

Nifurtimox for Treatment of Chagas Disease in Pediatric Patients: the Challenges of Applying Pharmacokinetic-Pharmacodynamic Principles to Dose Finding

2022 · Heino Stass, Ibrahim Ince, et al. · The AAPS Journal · 2

Investigation of bioequivalence, safety, and tolerability of a fixed-dose combination of nifedipine GITS and candesartan compared with the corresponding loose-dose combination under fed conditions

2019 · Dirk Thomas, Yuwang Liu, et al. · International Journal of Clinical Pharmacology and Therapeutics · 1

VEriciguat NItroglycerin Clinical IntEraction (VENICE): A phase 1, multicenter, randomized, placebo-controlled, double-blind group-comparison study in patients with stable coronary artery disease to evaluate tolerability and blood pressure effects of nitroglycerin after pre-treatment with multiple oral doses of vericiguat

2018 · Gerd Mikus, Michael F Boettcher, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society · 1

Investigation of bioequivalence of a new fixed-dose combination of nifedipine and candesartan with the corresponding loose combination as well as the drug-drug interaction potential between both drugs under fasting conditions

2013 · Erich Brendel, Boris Weimann, et al. · International Journal of Clinical Pharmacology and Therapeutics · 1

On Combining Exact and Approximative Proceedings for Testing Problems in Unbalanced Mixed Linear Models

2000 · Weimann, Boris · RePEc: Research Papers in Economics

Testing linear forms of variance components by generalized fixed-level tests

1998 · Weimann, Boris · RePEc: Research Papers in Economics

Works count: 14

Citation count: 186

H-index: 5

I10-index: 5